chr17-19648972-A-T

Variant summary

Our verdict is Pathogenic. Variant got 20 ACMG points: 20P and 0B. PVS1PS1_ModeratePM2PP5_Very_Strong

The NM_000382.3(ALDH3A2):​c.1A>T​(p.Met1?) variant causes a start lost change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000697 in 1,434,148 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

ALDH3A2
NM_000382.3 start_lost

Scores

3
7
6

Clinical Significance

Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 1.28
Variant links:
Genes affected
ALDH3A2 (HGNC:403): (aldehyde dehydrogenase 3 family member A2) Aldehyde dehydrogenase isozymes are thought to play a major role in the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation. This gene product catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acid. Mutations in the gene cause Sjogren-Larsson syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 20 ACMG points.

PVS1
Start lost variant, no new inframe start found.
PS1
Another start lost variant in NM_000382.3 (ALDH3A2) was described as [Likely_pathogenic] in ClinVar as 552722
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-19648972-A-T is Pathogenic according to our data. Variant chr17-19648972-A-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 551717.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ALDH3A2NM_000382.3 linkuse as main transcriptc.1A>T p.Met1? start_lost 1/10 ENST00000176643.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ALDH3A2ENST00000176643.11 linkuse as main transcriptc.1A>T p.Met1? start_lost 1/101 NM_000382.3 P1P51648-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.97e-7
AC:
1
AN:
1434148
Hom.:
0
Cov.:
30
AF XY:
0.00000141
AC XY:
1
AN XY:
710836
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
9.10e-7
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Likely pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Sjögren-Larsson syndrome Pathogenic:2
Likely pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJan 19, 2023Variant summary: ALDH3A2 c.1A>T (p.Met1?, aka p.Met1Leu) alters the initiation codon and is predicted to result either in absence of the protein or truncation of the encoded protein due to translation initiation at a downstream codon. The first potential downstream in-frame start codon (ATG) is located in the same exon, at Met33. Several other start-lost variants, and truncations upstream from Met33 have been reported in individuals affected with Sjogren-Larsson Syndrome (HGMD). The variant was absent in 201014 control chromosomes (gnomAD). To our knowledge, no occurrence of c.1A>T in individuals affected with Sjogren-Larsson Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, and classified the variant as likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Likely pathogenic, criteria provided, single submitterclinical testingCounsylMay 02, 2017- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.050
CADD
Uncertain
24
DANN
Benign
0.93
DEOGEN2
Benign
0.0060
.;T;.;.;T;.;T;.;T
Eigen
Uncertain
0.43
Eigen_PC
Uncertain
0.42
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.90
D;D;.;.;D;.;.;D;.
M_CAP
Pathogenic
0.98
D
MetaRNN
Pathogenic
0.98
D;D;D;D;D;D;D;D;D
MetaSVM
Uncertain
0.37
D
MutationTaster
Benign
1.0
D;D;D;D;D
PROVEAN
Benign
-0.82
N;.;.;.;N;.;N;N;.
REVEL
Uncertain
0.58
Sift
Benign
0.099
T;.;.;.;D;.;D;D;.
Sift4G
Benign
0.11
T;T;T;T;T;T;T;T;T
Polyphen
0.88, 0.93
.;.;.;.;P;P;P;P;P
Vest4
0.48, 0.74, 0.74, 0.61, 0.74, 0.86, 0.72
MutPred
0.87
Gain of methylation at R6 (P = 0.1297);Gain of methylation at R6 (P = 0.1297);Gain of methylation at R6 (P = 0.1297);Gain of methylation at R6 (P = 0.1297);Gain of methylation at R6 (P = 0.1297);Gain of methylation at R6 (P = 0.1297);Gain of methylation at R6 (P = 0.1297);Gain of methylation at R6 (P = 0.1297);Gain of methylation at R6 (P = 0.1297);
MVP
0.89
ClinPred
0.99
D
GERP RS
5.3
Varity_R
0.83
gMVP
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr17-19552285; API